Four Revelations from Minnesota’s First 340B Transparency Report
Drug Channels
DECEMBER 3, 2024
Below, I do a wicked deep dive into the data and highlight crucial implications about spending, profits, pharmacies, plans, patients, program integrity, and more. And don't forget to put on your ruby slippers and hear from Doctor of Thinkology Adam J. There are important limitations to these data.
Let's personalize your content